Gene Therapy

The use of DNA as a technique for treating disease is a key feature of gene therapy. This type of treatment is being investigated to either replacement of a mutated gene with a healthy copy, silence a mutated gene that is dysfunctional or insert a novel gene to help fight disease. Discover the latest research on gene therapy here.

January 21, 2022

[Regulation effect of siRNA on β-globin in erythrocytes of hemoglobin H disease].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
H L Cheng, R R Liu
January 21, 2022

Rapid characterization of adeno-associated virus (AAV) gene therapy vectors by mass photometry.

Gene Therapy
Di WuGrzegorz Piszczek
January 21, 2022
Comment / Editorial

Adeno-Associated Virus Delivery Limitations for Neurological Indications.

Human Gene Therapy
Hector Ribeiro Benatti, Heather L Gray-Edwards
January 21, 2022

Gene Therapy for Huntington's Disease: The Future Is in Gene Editing.

Human Gene Therapy
Ana Rita Batista
January 21, 2022

Astellas, Dyno to Develop Next-Generation Adeno-Associated Virus Vectors in Up-to-$1.6B Partnership.

Human Gene Therapy
Alex Philippidis
January 21, 2022

Acknowledgment of Reviewers 2021.

Human Gene Therapy
January 21, 2022
Open Access

Gene Therapy Targeting PCSK9.

Julius L KatzmannUlrich Laufs
January 21, 2022

Design and characterization of a salicylic acid-inducible gene expression system for Jurkat cells.

Journal of Biotechnology
Aarti DoshiPatrick C Cirino
January 21, 2022

Genome DNA Leakage of Adeno-Associated Virus Under Freeze-Thaw Stress.

International Journal of Pharmaceutics
Alex Yuechuan XuDingjiang Liu
January 20, 2022

Nuclear and mitochondrial DNA editing in human cells with zinc finger deaminases.

Nature Communications
Kayeong LimJin-Soo Kim
January 20, 2022

Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID-19.

Annals of Clinical and Translational Neurology
Alexandra C AppleJoanna Hellmuth
January 20, 2022

Loss-of-function mutations in the co-chaperone protein BAG5 cause dilated cardiomyopathy requiring heart transplantation.

Science Translational Medicine
Hideyuki HakuiYoshihiro Asano
January 20, 2022

The neuronal retromer can regulate both neuronal and microglial phenotypes of Alzheimer's disease.

Cell Reports
Yasir H QureshiScott A Small
January 19, 2022

Decoding the Kinetic Pathways toward a Lipid/DNA Complex of Alkyl Alcohol Cationic Lipids Formed in a Microfluidic Channel.

The Journal of Physical Chemistry. B
Dipanjan MukherjeeSamir Kumar Pal
January 19, 2022

Targeting PTPN22 does not enhance the efficacy of CAR T cells in solid tumours.

Molecular and Cellular Biology
Xin DuTony Tiganis
January 19, 2022
Open Access

Therapeutic potential of highly functional codon-optimized microutrophin for muscle-specific expression.

Scientific Reports
Anna V StarikovaMaryana V Bardina
January 18, 2022

Preparation and characterization of polyamidoamine dendrimers conjugated with cholesteryl-dipeptide as gene carriers in HeLa cells.

Journal of Biomaterials Science. Polymer Edition
Le Thi ThuyJoon Sig Choi

Sign up to follow this feed and discover related papers.

Related Feeds

AAV-based Gene Therapy

Adeno-associated virus (AAV)-based gene therapy is a biological vector that is being researched to be used as a potential therapeutic option. This gene therapy is designed to insert fragments of DNA into targeted cells to help treat diseases, such as hemophilia a. Discover the latest research on AAV-based gene therapy here.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Alzheimer's Disease: Genetics

Alzheimer's disease is a neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations with this feed.

Antisense Oligonucleotide Therapies: ND

Antisense oligonucleotides are synthetic DNA oligomers that hybridize to a target RNA. This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases.

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Breast Cancer: Risk Factors

Breast cancer is a multifactorial disease that is influenced by both environmental and genetic factors. Discover the latest research on the environmental and genetic risk factors for breast cancer here.

CFTR Mutant Structural Therapy

Over 1700 different mutations in the CFTR genes have been shown to cause cystic fibrosis. Here is the latest research on structural therapy for CFTR mutants.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

© 2022 Meta ULC. All rights reserved